Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

AI Policy

1. Purpose and Scope This policy establishes guidelines for the ethical, transparent, and responsible use of artificial intelligence (AI) in the operations, publishing, and editorial processes of a scholarly medical journal. The policy applies to authors, reviewers, editors, and journal staff.

2. Guiding Principles
2.1 Transparency: All uses of AI in research, writing, reviewing, or publishing must be disclosed explicitly to ensure clarity about its role.
2.2 Accountability: The responsibility for the integrity of the content lies with the authors and editorial team, irrespective of AI involvement.
2.3 Ethical Integrity: AI applications should comply with ethical standards, including respecting patient privacy, avoiding bias, and upholding scientific rigor.
2.4 Compliance with Standards: AI use must align with international and institutional policies, including COPE (Committee on Publication Ethics) guidelines.

3. Use of AI in Manuscript Preparation
3.1 Authorship: AI tools cannot be listed as an author. Only humans who meet authorship criteria as defined by the journal’s guidelines can be credited.
3.2 AI-Assisted Writing: Authors must disclose the use of AI tools (e.g., language editing or data analysis tools) in the Methods or Acknowledgment sections.
3.3 Originality: Authors must ensure that AI-generated content does not include plagiarized material and is adequately verified for accuracy.

4. Use of AI in Manuscript Submission and Review Processes
4.1 Submission Package Verification: This functionality scans all submitted documents, including the manuscript file, tables, and figure files, to ensure consistency with the instructions for authors. It identifies and lists any missing elements.
4.2 AI-Assisted Language Quality Evaluation: This tool evaluates the quality of manuscript writing and comprehension. Authors receive detailed recommendations for text improvements to ensure manuscripts meet high linguistic standards before peer review.
4.3 Manuscript Technical Review: AI-powered algorithms assess manuscripts for completeness, clarity, and conciseness. The review ensures that vital sections such as the abstract, introduction, methodology, results, discussion, and references are present and developed. This process aims at elimination of verbosity, enhancement of readability, and ensures technical and formal quality before scientific review.
4.4 Reference Check: AI tools check for duplicate references and verify compliance with the journal’s required citation style.
4.5 Abstract Refinement: This feature helps authors and editors refine abstracts to meet a 250-word limit while preserving structure and meaning. Authors must approve AI-powered edits.
4.6 Paper-Mill Detection: AI-driven tools identify manuscripts potentially originating from paper mills. By analyzing writing style, data consistency, literature integration, and author profiles, the tool assigns a score from 1 to 10 and provides justifications. This helps detect unethical submissions early and ensures the integrity of published research.
4.7 Verification Reports: The verification and check reports are presented to the authors for appropriate corrections or approval.

5. Use of AI in Peer Review and Editorial Processes
5.1 Editorial Use: Editors may use AI tools to assist in plagiarism detection, language editing, or identifying suitable reviewers. Such use must not replace human judgment.
5.2 Reviewer Use: Reviewers may use AI tools for language assistance but must not rely on AI to generate review content. Any such use should be disclosed to the editorial team.
5.3 Bias and Fairness: AI tools used in editorial decisions must be validated to ensure they do not introduce bias against specific demographics, geographies, or research disciplines.

6. Data Privacy and Security
6.1 Data Protection: All data shared with AI tools must comply with data protection regulations, such as GDPR or HIPAA, to safeguard patient and author information.
6.2 Third-Party Tools: Any third-party AI tools used by the journal must undergo rigorous vetting to ensure compliance with privacy and security standards.

7. Ethical Review and Compliance
7.1 Monitoring: The journal will regularly review AI applications to ensure compliance with ethical and scientific standards.
7.2 Policy Violations: Non-compliance with the AI policy may result in actions ranging from manuscript rejection to reporting to the author’s institution.

8. Education and Support
8.1 Training: The journal will provide resources and training to authors, reviewers, and editors on the responsible use of AI in scholarly publishing.
8.2 Feedback Mechanisms: Stakeholders can provide feedback on AI-related practices to continuously improve the policy.

9. Policy Review This AI policy will be reviewed and updated periodically to reflect advancements in AI technology, ethical standards, and scholarly publishing practices.

10. Contact Information Questions or concerns regarding the AI policy can be directed to the editorial office at International Scientific Information, Inc. 150 Broadhollow Rd., Suite 114 Melville, NY, 11747 | USA.

Last edited: 01/20/2025

In Press

Original article  

Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...

Ann Transplant In Press; DOI: 10.12659/AOT.951568  

Original article  

Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver Transplantation

Ann Transplant In Press; DOI: 10.12659/AOT.950589  

Database Analysis  

Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...

Ann Transplant In Press; DOI: 10.12659/AOT.950289  

Original article  

Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...

Ann Transplant In Press; DOI: 10.12659/AOT.950997  

Most Viewed Current Articles

24 Aug 2021 : Review article   18,372

Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives

DOI :10.12659/AOT.931664

Ann Transplant 2021; 26:e931664

05 Apr 2022 : Original article   14,731

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

22 Nov 2022 : Original article   14,244

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

29 Dec 2021 : Original article   13,752

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358